Astellas Pharma Inc.

07/12/2021 | Press release | Distributed by Public on 07/11/2021 17:30

U.S. FDA Grants Regular Approval and Expands Indication for PADCEV(enfortumab vedotin) for Patients with Locally Advanced or Metastatic Urothel cancer